22(S)-Hydroxycholesterol, an antagonist of LXR, inhibits breast cancer cell migration

被引：0
|
作者：
Hwang, Sewon
Na, Tae Young
Na, Hyelin
Lee, Minho
Lee, Mi-Ock
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1637
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1637
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Cryptanshinone Inhibits the Glycolysis and Inhibits Cell Migration Through PKM2/β-Catenin Axis in Breast Cancer
    Zhou, Jiefeng
    Su, Chih-Ming
    Chen, Hsin-An
    Du, Shicong
    Li, Chang-Wei
    Wu, Haoran
    Tsai, Shin-Han
    Yeh, Yu-Ting
    ONCOTARGETS AND THERAPY, 2020, 13 : 8629 - 8639
  • [32] Anandamide inhibits adhesion and migration of breast cancer cells
    Grimaldi, C
    Pisanti, S
    Laezza, C
    Malfitano, AM
    Santoro, A
    Vitale, M
    Caruso, MG
    Notarnicola, M
    Iacuzzo, I
    Portella, G
    Di Marzo, V
    Bifulco, M
    EXPERIMENTAL CELL RESEARCH, 2006, 312 (04) : 363 - 373
  • [33] Dendroflorin inhibits lung cancer cell migration
    Kesarin Busaranon
    Varisa Pongrakhananon
    Boonchoo Sritularak
    Pithi Chanvorachote
    Asian Journal of Pharmaceutical Sciences, 2016, 11 (01) : 179 - 180
  • [34] The BCL2 Antagonist of Death, BAD Is Down-Regulated in Breast Cancer and Inhibits Cancer Cell Invasion
    Cekanova, M.
    Fernando, R.
    Wimalasena, J.
    CANCER RESEARCH, 2011, 71
  • [35] Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways
    Zhenjiang Zhao
    Guoguo Jin
    Yinghui Ge
    Zhiping Guo
    Inflammopharmacology, 2019, 27 : 1021 - 1036
  • [36] Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways
    Zhao, Zhenjiang
    Jin, Guoguo
    Ge, Yinghui
    Guo, Zhiping
    INFLAMMOPHARMACOLOGY, 2019, 27 (05) : 1021 - 1036
  • [37] IR-783 inhibits breast cancer cell proliferation and migration by inducing mitochondrial fission
    Li, Pantong
    Liu, Yu
    Liu, Wuyi
    Li, Guobing
    Tang, Qin
    Zhang, Qian
    Leng, Faning
    Sheng, Fangfang
    Hu, Changpeng
    Lai, Wenjing
    Liu, Yali
    Zhou, Min
    Huang, Jingbin
    Zhou, Huyue
    Zhang, Rong
    Zhao, Yu
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 55 (02) : 415 - 424
  • [38] Knockdown of KIF26B inhibits breast cancer cell proliferation, migration, and invasion
    Gu, Shudong
    Liang, Haibin
    Qi, Donghui
    Mao, Liyan
    Mao, Guoxin
    Qian, Li
    Zhang, Shu
    ONCOTARGETS AND THERAPY, 2018, 11 : 3195 - 3203
  • [39] FRK inhibits breast cancer cell migration and invasion by suppressing epithelial-mesenchymal transition
    Ogunbolude, Yetunde
    Dai, Chenlu
    Bagu, Edward T.
    Goel, Raghuveera Kumar
    Miah, Sayem
    MacAusland-Berg, Joshua
    Ng, Chi Ying
    Chibbar, Rajni
    Napper, Scott
    Raptis, Leda
    Vizeacoumar, Frederick
    Vizeacoumar, Franco
    Bonham, Keith
    Lukong, Kiven Erique
    ONCOTARGET, 2017, 8 (68) : 113034 - 113065
  • [40] Development of a JNK2-selective peptide inhibitor that inhibits breast cancer cell migration
    Kaoud, Tamer S.
    Mitra, Shreya
    Lee, Sunbae
    Taliaferro, Juliana
    Van Den Berg, Carla
    Dalby, Kevin N.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
12345